Iterum Therapeutics plc (ITRM:NASDAQ) rocketted at $0.34, representing a gain of 40.4%. On Mon, Jul 11, 2022, ITRM:NASDAQ touched a New 2-Week High of $0.34. The stock got featured on our News Catalysts scanner on Mon, Jul 11, 2022 at 08:05 AM in the 'AGREEMENT' category. From Mon, Jun 27, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Mon, Jul 11, 2022 at $0.47 with a volume of 157M+.
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Kaspien Holdings Inc. (KSPN:NASDAQ), 161.92%
- Pliant Therapeutics Inc. (PLRX:NASDAQ), 159.01%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 81.12%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Iterum Therapeutics plc (ITRM:NASDAQ), 40.42%
- Volcon Inc. (VLCN:NASDAQ), 40%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 34.38%
- SQL Technologies Corp. (SKYX:NASDAQ), 32.56%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 27.23%
- Kalera Public Limited Company (KAL:NASDAQ), 20.35%